Ribosomal S6 kinase 4 (RSK4) is a tumor suppressor gene product (also known as RPS6KA6) that has been shown to be significantly downregulated in multiple malignancies—including those of the breast, colon, kidney, ovarian, and acute myeloid leukemia [20–27]; and it can inhibit tumor cell proliferation, invasion, and the epithelial mesenchymal transformation [28, 29]. Here, RPS6KA6 is linked to neoplasm.